IRIS
MINISINI, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.608
NA - Nord America 4.314
AS - Asia 2.913
SA - Sud America 426
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 101
OC - Oceania 3
Totale 12.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.165
RU - Federazione Russa 1.144
SG - Singapore 948
IT - Italia 771
IE - Irlanda 755
CN - Cina 622
DE - Germania 501
HK - Hong Kong 372
VN - Vietnam 365
BR - Brasile 328
SE - Svezia 321
FR - Francia 316
UA - Ucraina 220
IN - India 191
FI - Finlandia 147
GB - Regno Unito 117
BD - Bangladesh 99
CZ - Repubblica Ceca 94
CA - Canada 82
KR - Corea 77
ID - Indonesia 56
AT - Austria 46
BJ - Benin 44
PL - Polonia 43
MX - Messico 39
TR - Turchia 39
AR - Argentina 37
NL - Olanda 34
ES - Italia 33
IQ - Iraq 24
ZA - Sudafrica 22
BE - Belgio 20
JP - Giappone 19
EC - Ecuador 16
IR - Iran 16
UZ - Uzbekistan 12
VE - Venezuela 11
LT - Lituania 10
CL - Cile 9
PH - Filippine 9
CO - Colombia 8
EU - Europa 8
CH - Svizzera 7
PK - Pakistan 7
PY - Paraguay 7
SA - Arabia Saudita 7
EG - Egitto 6
MA - Marocco 6
PT - Portogallo 6
TN - Tunisia 6
HN - Honduras 5
JM - Giamaica 5
KE - Kenya 5
MD - Moldavia 5
NP - Nepal 5
PE - Perù 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
IL - Israele 4
KZ - Kazakistan 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JO - Giordania 3
MY - Malesia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GT - Guatemala 2
HR - Croazia 2
LB - Libano 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 12.367
Salva come PNG Salva come JPEG
Città #
Dublin 743
San Jose 547
Hong Kong 371
Jacksonville 370
Singapore 330
Ashburn 314
Council Bluffs 278
Beijing 188
Dearborn 182
Novara 140
Columbus 138
Chandler 132
Moscow 130
Los Angeles 128
Ho Chi Minh City 110
Milan 103
Piemonte 97
Hanoi 93
Lauterbourg 92
Wilmington 87
Lawrence 81
Princeton 81
Munich 79
New York 78
Buffalo 74
Seoul 68
Ann Arbor 67
Turin 60
San Mateo 59
Santa Clara 57
São Paulo 52
Cotonou 44
Frankfurt am Main 41
Jakarta 41
Andover 38
Nuremberg 38
Vercelli 38
Orem 36
Brno 35
Dallas 34
Pardubice 34
Warsaw 34
Denver 31
Brooklyn 30
Helsinki 30
Chennai 28
London 28
Chicago 26
Boardman 25
Falkenstein 24
Amsterdam 23
Atlanta 22
Houston 22
Bremen 21
Montreal 21
Toronto 21
Brussels 20
Nanjing 20
Vienna 20
Stockholm 19
Turku 19
Guangzhou 18
Mexico City 18
Poplar 18
Shanghai 18
The Dalles 18
Tokyo 17
Düsseldorf 16
Hillsboro 16
Johannesburg 15
Phoenix 15
Rome 15
Mumbai 14
České Budějovice 14
Redondo Beach 12
Biên Hòa 11
Bologna 11
Boston 11
Seattle 11
Charlotte 10
Dong Ket 10
Hefei 10
Marseille 10
Mülheim 10
Tashkent 10
Tianjin 10
Ankara 9
Brescia 9
Cassano Magnago 9
Haiphong 9
Jinan 9
New Delhi 9
Norwalk 9
Ottawa 9
Philadelphia 9
Brasília 8
Da Nang 8
Guayaquil 8
Manchester 8
Stankov 8
Totale 6.651
Salva come PNG Salva come JPEG
Nome #
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 232
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 196
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 194
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 180
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 175
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 171
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 169
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 162
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 162
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 162
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 156
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 156
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 155
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 152
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 152
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 151
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 148
Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy 144
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 143
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 143
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 143
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 142
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 142
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 140
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 139
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 138
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 137
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 136
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 135
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 132
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 132
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 131
Understanding protection from SARS-CoV-2 using metabolomics 131
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 128
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 127
Influence of age on sex-related differences among patients with hepatitis C. 126
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 126
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 124
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 122
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 121
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 120
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 118
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 118
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 117
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 117
ACE genotype, body weight changes and target organ damage in renal transplant recipients 116
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 116
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters 115
Recent advances in HCV entry 113
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 113
Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease 112
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 112
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 112
Severity of nonalcoholic fatty liver disease in type 2 diabetes mellitus: Relationship between nongenetic factors and PNPLA3/HSD17B13 polymorphisms 112
Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment 111
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 109
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 108
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 107
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 106
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 106
Circadian control of hepatitis B virus replication 106
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis 106
Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms? 105
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 104
Interferon-stimulated gene pathways in the treatment of viral hepatitis 103
Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro 103
Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections 101
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 100
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship 99
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 99
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 98
Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects 97
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 96
Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipose Tissue and Inflammation 96
INTERLEUKIN 6 PROMOTER POLYMORPHISMS INFLUENCE THE OUTCOME OF CHRONIC HEPATITIS C 95
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 95
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome 94
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 93
Evaluation of donor hepatic iron concentration as a factor of early fibrotic progression after liver transplantation 91
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 90
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 89
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns 87
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 87
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 87
Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C 86
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 85
TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer 85
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 84
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 84
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation 83
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 83
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 83
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype 81
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 80
From MASH to HCC: the role of Gas6/TAM receptors 78
MTHFR C677T Polymorphism and Risk of HCC in Patients With Liver Cirrhosis: Role of Male Gender and Alcohol Consumption 78
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 77
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC 75
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 75
Pegylated Vs. conventional interferon–alpha in antiviral regimens for recurrent hepatitis C: a comparison of tolerability and efficacy 73
Totale 11.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 0 23 80 39 29 0 46 19 43 40 81 124
2022/20231.513 153 74 84 16 69 116 59 52 762 13 81 34
2023/2024919 54 108 51 25 152 39 186 29 23 43 68 141
2024/20251.687 41 30 91 33 55 91 188 164 341 120 153 380
2025/20265.618 265 215 301 750 607 354 853 900 410 443 323 197
2026/2027545 213 332 0 0 0 0 0 0 0 0 0 0
Totale 12.585